Singapore markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.40-1.32 (-4.60%)
As of 03:58PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
35,000
0
0
Operating expenses
Research development
124,337
101,676
51,859
42,545
9,898
Selling general and administrative
102,834
71,792
29,465
16,694
8,593
Total operating expenses
227,171
173,468
81,324
59,239
18,491
Operating income or loss
-227,171
-173,468
-46,324
-59,239
-18,491
Total other income/expenses net
-1,623
-1,140
-580
-2,614
-
Income before tax
-227,964
-173,910
-45,574
-58,306
-17,813
Income from continuing operations
-227,964
-173,910
-45,574
-58,306
-17,813
Net income
-227,964
-173,910
-45,574
-58,306
-17,813
Net income available to common shareholders
-227,964
-173,910
-45,574
-50,577
-17,813
Basic EPS
-
-3.59
-1.05
-3.81
-2.00
Diluted EPS
-
-3.59
-1.05
-3.81
-2.00
Basic average shares
-
48,498
43,300
13,275
8,927
Diluted average shares
-
48,498
43,300
13,275
8,927
EBITDA
-
-172,978
-45,975
-59,047
-18,474